What is Fingolimod Clinical Trial?
CATEGORY: Others
TYPES:Generic: Fingolimod Clinical TrialBrand:
FTY720 is the name used during clinical trials for the drug fingolimod. On September 22, 2010, fingolimod became the first oral disease modifying drug approved by the FDA as Gilenya to reduce relapses and delay disability progression in patients with relapsing forms of multiple sclerosis.
Save up to 80% off your prescriptions!
How do members experience Fingolimod Clinical Trial?
Top 5 reported purposes & perceived effectiveness
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Multiple sclerosis | 44 | 51 | |
| Participate in clinical trial | 14 | 17 | |
| Amyotrophic lateral sclerosis | 1 | 2 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Heart rate low (bradycardia) | 5 | |
| Nausea | 4 | |
| Hair loss | 3 | |
| Acid reflux | 2 | |
| Diarrhea | 2 | |
| Flatulence | 2 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 8 | |
| Mild | 22 | |
| None | 33 |
Member evaluations
AK_Drifter
evaluated on Jan 24, 2011
- Perceived effectiveness for transplant rejection prevention: Can't tell
- Side effects: None
JesswithMS
evaluated on Sep 22, 2010
- Perceived effectiveness for multiple sclerosis: Moderate
- Side effects: Mild
shenannigans99
evaluated on Aug 03, 2010
- Perceived effectiveness for Participate in clinical trial: Moderate
- Side effects: None
Learn more about our community’s experience with Fingolimod Clinical Trial
What are people saying about Fingolimod Clinical Trial?
74
74
members have reported taking Fingolimod Clinical Trial
Join the conversation and connect with people who have taken Fingolimod Clinical Trial
Last updated: